Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

NCT00767221 is registered in ClinicalTrials.gov with Calliditas Therapeutics AB as lead sponsor.

NCT NCT00767221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00767221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
Lead sponsor
Calliditas Therapeutics AB
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
November 30, 2008
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy